ClinicalTrials.gg
RecruitingNCT06574672Updated Jul 16, 2025

Embedded Palliative Care in the MICU

An interventional study of Embedded Hospice and Palliative Care Practitioner and Embedded Hospice and Palliative Care Practitioner (Group Effect) in Critical Illness, End of Life and Quality of Life, sponsored by Washington University School of Medicine. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-16.

Primary conditionDeathRegistry: Critical IllnessReclassifiedWhy we changed it
Registry
Critical Illness — the first condition term the registry derived for this study.
ClinicalTrials.gg
Death
Why
  1. Critical Illness is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Death.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
2,600
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to investigate whether embedding a hospice and palliative care practitioner within a medical intensive care unit will improve patient outcomes and healthcare usage. The practitioner will work solely within the medical intensive care units and offer timely as well as proactive consultations based on clinical criteria and estimated mortality risk. The study team will compare patients seen by the practitioner to patients in an adjacent ICU and historical patients to determine whether patient care is improved by this intervention.

Read the detailed description

The study goal is to determine whether an embedded palliative care practitioner in the medical ICU improves patient outcomes, palliative care/hospice utilization, and healthcare quality metrics. The medical ICUs included in this study are comprised of two geographically co-located units that provide care for medically complex patients from a large tertiary referral area. Palliative care services are currently available as a consultative service at the ICU clinicians' discretion for patients with palliative needs such as complex goals of care, advanced symptom management, or chronic critical illness. Under the current consultation model, palliative care consultation is requested in a minority of critically ill patients and consults occur on average 5-14 days after a patient's admission. Hospice services are similarly available on a consultative basis for patients that the primary team has determined are suitable for hospice, however, logistical limitations of hospice consultation may lead to delays in inpatient hospice transfers and home hospice discharges.

This study's intervention is to embed a palliative care/hospice practitioner within the medical ICUs as a dedicated palliative care and hospice consultant who will offer proactively triggered palliative care consultations early in a patient's ICU stay as well as immediate availability for standard-of-care palliative care and hospice consultations.

02

Conditions studied

  • Critical Illness
  • End of Life
  • Quality of Life

Browse trials for

Keywords

  • Palliative Care
  • Hospice
  • Medical ICU
03

In context

Death Reclassified

456 studies on the registry are indexed under Death; 86 are open to participants now.

This study's planned enrollment of 2,600 is above the median of 163 across 210 interventional studies indexed under Death.

Browse Death studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,803 studies on the registry; 271 are open to participants now.

Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.

Compared within Death, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Critical Illness. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients admitted to the medical intensive care units at a tertiary referral center
  • Patients must be at least 18 years of age

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
2,600 participants (estimated)

Study arms

  • Experimental
    Prospective Hospice and Palliative Care Intervention

    This arm comprises patients admitted to the specific medical intensive care unit in which the hospice and palliative care practitioner is currently active. This will include all patients admitted to a single medical intensive care unit during the anticipated first half of the intervention timeframe, followed by all patients admitted to both medical intensive care units during the second half of the intervention timeframe.

    Other: Embedded Hospice and Palliative Care Practitioner

  • Active comparator
    Prospective Standard of Care

    This arm comprises patients admitted to the medical intensive care unit in which the hospice and palliative care practitioner is not currently active, but which may experience a group effect due to the study's ongoing enrollment and the practitioner's presence. This will include all patients admitted to a single medical intensive care unit during the anticipated first half of the intervention timeframe, prior to the practitioner becoming active in both intensive care units.

    Other: Embedded Hospice and Palliative Care Practitioner (Group Effect)

  • Placebo comparator
    Historical Controls

    This arm comprises historical patients admitted to the medical intensive care units in the year prior to study enrollment.

    Other: None (Historical)

Interventions

  • OtherEmbedded Hospice and Palliative Care Practitioner

    The hospice and palliative care practitioner will be embedded in one medical intensive care unit for the first half of the study timeframe, after which the practitioner will expand to both medical intensive care units. While active in a medical intensive care unit, the practitioner will proactively trigger palliative care consultations based on clinical criteria and estimated mortality risk, in addition to providing immediate availability for standard-of-care hospice or palliative care consultations.

  • OtherEmbedded Hospice and Palliative Care Practitioner (Group Effect)

    While the hospice and palliative care practitioner is active in one medical intensive care unit with respect to triggering consultations, the other medical intensive care unit can still utilize the practitioner's services for standard-of-care hospice or palliative care consultations.

  • OtherNone (Historical)

    This control arm includes historical patients admitted to the medical intensive care units prior to the study's enrollment timeframe.

06

What researchers measure

Primary outcomes

  1. ICU Length of Stay

    Length of stay in any intensive care unit during the hospitalization

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  2. Code Status De-escalation

    Frequency of changes in code status to limited code or comfort measures only

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

Secondary outcomes

  1. Presence of Advance Care Planning Documentation during Current Admission

    Documentation of advance directives, limitations in life-sustaining treatments, or code status that is newly created during the active hospital admission

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  2. Hospice Consultation

    Frequency of Hospice consultations

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  3. Hospice Enrollment

    Frequency of discharge or transition to hospice during or immediately following the hospital stay

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  4. Palliative Care Consultation

    Frequency of Palliative Care consultations

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  5. Time to change in code status, advance care planning documentation, palliative care consultation, and hospice consultation

    Time in days to the first occurrence of the above outcomes

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  6. Inpatient Hospice Duration

    Days while patients are enrolled in inpatient hospice (GIP)

    Time frame: From date of enrollment until hospital or hospice discharge, assessed up to 1 year

  7. Location of discharge disposition

    Discharge disposition to home, skilled nursing facility, long term acute care facility, inpatient rehabilitation, etc.

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  8. Hospital Length of Stay

    Length of hospital stay in days

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  9. Mortality Index (Vizient)

    Mortality index as calculated by Vizient

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  10. Length of Stay Index (Vizient)

    Length of stay index as calculated by Vizient

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  11. Operating cost in dollars, including departmental breakdown

    Hospital operating cost for each patient, including departmental breakdown such as ICU, pharmacy, procedural, operating room, etc.

    Time frame: Assessed six months following discharge

  12. Mechanical Ventilation Duration

    Days on mechanical ventilation

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  13. Vasopressor Utilization

    Days on vasopressors

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  14. Hospital Mortality

    Inpatient all-cause mortality

    Time frame: From date of enrollment until hospital discharge, assessed up to 1 year

  15. 30-Day Mortality

    All-cause mortality within 30 days of hospital admission

    Time frame: Assessed 30 days after hospital admission

  16. 30-day Emergency Room Visit

    Emergency Room encounter in the same healthcare system within 30 days of discharge

    Time frame: Assessed 30 days after hospital discharge

  17. 30-day Readmission

    Hospital readmission in the same healthcare system within 30 days of discharge

    Time frame: Assessed 30 days after hospital discharge

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Aslakson R, Cheng J, Vollenweider D, Galusca D, Smith TJ, Pronovost PJ. Evidence-based palliative care in the intensive care unit: a systematic review of interventions. J Palliat Med. 2014 Feb;17(2):219-35. doi: 10.1089/jpm.2013.0409. PubMed 24517300 ↗
  • Khandelwal N, Kross EK, Engelberg RA, Coe NB, Long AC, Curtis JR. Estimating the effect of palliative care interventions and advance care planning on ICU utilization: a systematic review. Crit Care Med. 2015 May;43(5):1102-11. doi: 10.1097/CCM.0000000000000852. PubMed 25574794 ↗
  • Kyeremanteng K, Gagnon LP, Thavorn K, Heyland D, D'Egidio G. The Impact of Palliative Care Consultation in the ICU on Length of Stay: A Systematic Review and Cost Evaluation. J Intensive Care Med. 2018 Jun;33(6):346-353. doi: 10.1177/0885066616664329. Epub 2016 Aug 31. PubMed 27582396 ↗
  • Braus N, Campbell TC, Kwekkeboom KL, Ferguson S, Harvey C, Krupp AE, Lohmeier T, Repplinger MD, Westergaard RP, Jacobs EA, Roberts KF, Ehlenbach WJ. Prospective study of a proactive palliative care rounding intervention in a medical ICU. Intensive Care Med. 2016 Jan;42(1):54-62. doi: 10.1007/s00134-015-4098-1. Epub 2015 Nov 10. PubMed 26556622 ↗
  • Helgeson SA, Burnside RC, Robinson MT, Mack RC, Ball CT, Guru PK, Moss JE. Early Versus Usual Palliative Care Consultation in the Intensive Care Unit. Am J Hosp Palliat Care. 2023 May;40(5):544-551. doi: 10.1177/10499091221115732. Epub 2022 Jul 14. PubMed 35833450 ↗
  • Ma J, Chi S, Buettner B, Pollard K, Muir M, Kolekar C, Al-Hammadi N, Chen L, Kollef M, Dans M. Early Palliative Care Consultation in the Medical ICU: A Cluster Randomized Crossover Trial. Crit Care Med. 2019 Dec;47(12):1707-1715. doi: 10.1097/CCM.0000000000004016. PubMed 31609772 ↗
  • Chi S, Kim S, Reuter M, Ponzillo K, Oliver DP, Foraker R, Heard K, Liu J, Pitzer K, White P, Moore N. Advanced Care Planning for Hospitalized Patients Following Clinician Notification of Patient Mortality by a Machine Learning Algorithm. JAMA Netw Open. 2023 Apr 3;6(4):e238795. doi: 10.1001/jamanetworkopen.2023.8795. PubMed 37071421 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06574672
Responsible party
Stephen Wen-Yan Chi (Assistant Professor, Washington University School of Medicine) — Principal investigator
First posted
Aug 28, 2024
Start date
Jul 29, 2024
Primary completion
Jun 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Jul 16, 2025

Study contacts

Stephen Chi, MD
Contact
chis@wustl.edu
314-273-6176
Stephen Chi, MD
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion